US Patent Issued to EIP Pharma on Sept. 15 for "Treatment of a selective population of patients having dementia with Lewy bodies" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,174, issued on Sept. 15, was assigned to EIP Pharma LLC (Boston).

"Treatment of a selective population of patients having dementia with Lewy bodies" was invented by John Jahangir Alam (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods and compositions for the treatment of subjects that have Dementia with Lewy Bodies (DLB) but have no substantial tau pathology. Subjects with DLB that have no substantial tau pathology are shown to be particularly responsive to treatment with a selective p38Alpha mitogen activated protein kinase (MAPK) inhibitor compared to subjects with DLB that have substantial tau patholog...